
Boston Scientific Corporation: updates and filings
Price
$43.64
November 18, 2026Market cap $64.8B
What Ploutos Investor adds for Boston Scientific
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 28, 2026next Jan 28, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 17, 2026Officer or director change, other material eventsForm8-K
- Nov 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 2, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 28, 2026Results of operationsForm8-K
- Oct 7, 2026Officer or director change, other material eventsForm8-K
- Sep 23, 2026Officer or director changeForm8-K
- Sep 8, 2026Material cybersecurity incidentForm8-K
- Aug 26, 2026Other material eventsForm8-K
- Aug 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 3, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Results of operationsForm8-K
- Jul 27, 2026Restructuring costsForm8-K
- Jun 24, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 21, 2026Conflict minerals reportFormSD
- May 18, 2026Other material eventsForm8-K
- May 18, 2026Other material eventsForm8-K
- May 8, 2026Shares registered for employeesFormS-8
- May 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 5, 2026Amended articles or bylaws, shareholder voteForm8-K
- May 1, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 22, 2026FilingForm425
- Apr 22, 2026Results of operationsForm8-K
- Apr 1, 2026FilingFormEFFECT
- Mar 30, 2026Correspondence with the SECFormCORRESP
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 17, 2026 | 8-K | Officer or director change, other material events | Document |
| Nov 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 2, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 28, 2026 | 8-K | Results of operations | Document |
| Oct 7, 2026 | 8-K | Officer or director change, other material events | Document |
| Sep 23, 2026 | 8-K | Officer or director change | Document |
| Sep 8, 2026 | 8-K | Material cybersecurity incident | Document |
| Aug 26, 2026 | 8-K | Other material events | Document |
| Aug 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 3, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | 8-K | Results of operations | Document |
| Jul 27, 2026 | 8-K | Restructuring costs | Document |
| Jun 24, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 21, 2026 | SD | Conflict minerals report | Document |
| May 18, 2026 | 8-K | Other material events | Document |
| May 18, 2026 | 8-K | Other material events | Document |
| May 8, 2026 | S-8 | Shares registered for employees | Document |
| May 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 5, 2026 | 8-K | Amended articles or bylaws, shareholder vote | Document |
| May 1, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 22, 2026 | 425 | Filing | Document |
| Apr 22, 2026 | 8-K | Results of operations | Document |
| Apr 1, 2026 | EFFECT | Filing | Document |
| Mar 30, 2026 | CORRESP | Correspondence with the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 9, 1995: every report, 8-K, meeting and letter. Of its other filings (1,087 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 60.
The full analysis
What do Boston Scientific's filings show?
The filings are where every one of Boston Scientific's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.